NCT03572998View on ClinicalTrials.gov

Lymphatic Function in Patients Who Have Undergone Breast Cancer Treatment

NAUnknownINTERVENTIONAL

Enrollment

28

Participants

Timeline

Start Date

September 30, 2018

Primary Completion Date

February 28, 2019

Study Completion Date

August 31, 2019

Conditions

Secondary Lymphedema

Interventions

DRUG

Indocyanine Green (ICG)

Injection of ICG as a fluorophore for Near Infrared fluorescence Imaging (NIRF)

Trial Locations (1)

8000

RECRUITING

Aarhus University, Aarhus C

Sponsors

Collaborators (1)

Novo Nordisk A/S

All Listed Sponsors

collaborator

Novo Nordisk A/S

INDUSTRY

lead

University of Aarhus

OTHER

NCT03572998 - Lymphatic Function in Patients Who Have Undergone Breast Cancer Treatment | Biotech Hunter | Biotech Hunter